Aug 24, 2026 06:30PM
Aug 24, 2026 06:30PM
Jul 13, 2026 07:01AM
Jul 13, 2026 07:00AM
Jun 17, 2026 04:15PM
Jun 17, 2026 04:15PM
Jun 15, 2026 07:02AM Alkermes receives orphan drug status for alixorexton in U.S. and Europe
Jun 15, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 4, 2026 07:00AM
May 26, 2026 07:00AM
May 21, 2026 07:00AM
May 12, 2026 07:00AM
May 12, 2026 07:00AM Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia
Apr 16, 2026 07:00AM
Apr 16, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 14, 2026 07:00AM
Apr 1, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 24, 2026 08:52AM Alkermes (ALKS) PT Lowered to $43 at Piper Sandler
Feb 25, 2026 06:55AM
Feb 25, 2026 06:55AM
Feb 12, 2026 07:30AM
Feb 12, 2026 07:30AM
Jan 6, 2026 07:04AM
Jan 6, 2026 07:00AM
Nov 19, 2025 06:00AM Alkermes increases Avadel acquisition offer to $22.50 per share
Nov 19, 2025 06:00AM
Nov 17, 2025 05:52AM
Nov 17, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 14, 2025 05:45AM
Nov 12, 2025 09:57AM
Oct 28, 2025 07:00AM Alkermes plc Reports Third Quarter 2025 Financial Results
Oct 22, 2025 07:00AM
Oct 22, 2025 07:00AM
Sep 10, 2025 09:16AM
Jul 29, 2025 07:00AM
Jun 2, 2025 07:00AM
May 1, 2025 07:00AM
Feb 12, 2025 07:00AM Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2024 and Provides Financial Expectations for 2025
Jan 29, 2025 09:12AM
Jan 6, 2025 10:35AM
Jan 2, 2025 01:02PM
Oct 24, 2024 07:00AM
Jul 24, 2024 07:00AM
May 14, 2024 07:00AM
May 1, 2024 07:00AM Alkermes plc Reports First Quarter 2024 Financial Results
Apr 8, 2024 07:22AM

329,752 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All